Peptide drugs: a new direction in cancer immunotherapy
Cancer Biol Med
.
2023 Dec 7;21(3):198-203.
doi: 10.20892/j.issn.2095-3941.2023.0297.
Authors
Xinghua Sui
1
,
Xiaoshuang Niu
1
,
Xiuman Zhou
1
,
Yanfeng Gao
1
Affiliation
1
School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
PMID:
38062861
PMCID:
PMC10976324
DOI:
10.20892/j.issn.2095-3941.2023.0297
No abstract available
Publication types
Editorial
MeSH terms
Humans
Immunotherapy
Neoplasms* / drug therapy
Peptides*
Substances
Peptides
Grants and funding
U20A20369/National Natural Science Foundation of China
2022B1515120085/GuangDong Basic and Applied Basic Research Foundation